Teacher Retirement System of Texas acquired a new position in shares of Hologic, Inc. (NASDAQ:HOLX) in the 4th quarter, HoldingsChannel reports. The fund acquired 77,581 shares of the medical equipment provider’s stock, valued at approximately $3,317,000.
Other large investors have also added to or reduced their stakes in the company. Chevy Chase Trust Holdings Inc. boosted its position in shares of Hologic by 1.4% during the 3rd quarter. Chevy Chase Trust Holdings Inc. now owns 244,620 shares of the medical equipment provider’s stock worth $8,975,000 after acquiring an additional 3,391 shares in the last quarter. Janus Henderson Group PLC boosted its position in shares of Hologic by 15.5% during the 3rd quarter. Janus Henderson Group PLC now owns 285,035 shares of the medical equipment provider’s stock worth $10,458,000 after acquiring an additional 38,283 shares in the last quarter. Cipher Capital LP boosted its position in shares of Hologic by 57.9% during the 3rd quarter. Cipher Capital LP now owns 117,673 shares of the medical equipment provider’s stock worth $4,317,000 after acquiring an additional 43,146 shares in the last quarter. Ladenburg Thalmann Financial Services Inc. boosted its position in shares of Hologic by 66.4% during the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 12,487 shares of the medical equipment provider’s stock worth $458,000 after acquiring an additional 4,984 shares in the last quarter. Finally, GSA Capital Partners LLP boosted its position in shares of Hologic by 379.5% during the 3rd quarter. GSA Capital Partners LLP now owns 63,760 shares of the medical equipment provider’s stock worth $2,339,000 after acquiring an additional 50,463 shares in the last quarter. 95.24% of the stock is owned by institutional investors and hedge funds.
Several research analysts have recently issued reports on the company. Cowen raised Hologic to a “buy” rating and set a $52.00 price objective for the company in a research report on Wednesday, December 20th. Deutsche Bank downgraded Hologic from a “buy” rating to a “hold” rating and set a $49.00 target price for the company. in a report on Friday, January 19th. Zacks Investment Research raised Hologic from a “sell” rating to a “hold” rating in a report on Tuesday, October 31st. Stifel Nicolaus downgraded Hologic from a “buy” rating to a “hold” rating and reduced their target price for the company from $45.00 to $42.00 in a report on Friday, February 9th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $50.00 target price on shares of Hologic in a report on Friday, November 3rd. One research analyst has rated the stock with a sell rating, four have assigned a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. Hologic currently has a consensus rating of “Buy” and an average target price of $48.00.
In other Hologic news, Director Namal Nawana bought 6,600 shares of the business’s stock in a transaction dated Tuesday, February 13th. The stock was acquired at an average cost of $37.88 per share, with a total value of $250,008.00. Following the purchase, the director now owns 6,954 shares in the company, valued at approximately $263,417.52. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 0.88% of the company’s stock.
Shares of Hologic, Inc. (HOLX) opened at $39.29 on Monday. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.98 and a current ratio of 1.25. The company has a market capitalization of $10,864.83, a P/E ratio of 19.17, a price-to-earnings-growth ratio of 1.77 and a beta of 0.77. Hologic, Inc. has a one year low of $35.33 and a one year high of $46.80.
Hologic (NASDAQ:HOLX) last posted its quarterly earnings data on Thursday, February 8th. The medical equipment provider reported $0.55 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.50 by $0.05. The firm had revenue of $791.10 million during the quarter, compared to the consensus estimate of $785.80 million. Hologic had a return on equity of 20.07% and a net margin of 34.53%. The firm’s revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the business earned $0.52 EPS. equities research analysts predict that Hologic, Inc. will post 2.25 earnings per share for the current year.
ILLEGAL ACTIVITY NOTICE: “77,581 Shares in Hologic, Inc. (HOLX) Acquired by Teacher Retirement System of Texas” was originally reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://www.thelincolnianonline.com/2018/02/19/77581-shares-in-hologic-inc-holx-acquired-by-teacher-retirement-system-of-texas.html.
Hologic, Inc is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays.
Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).
Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.